Since PARP10 is mostly overexpressed in breast or ovarian tumors, we first created an isogenic PARP10 overexpression genetic system by exogenously expressing PARP10 under the doxycycline-inducible TRE promoter in the non-cancer breast epithelial cell line MCF10A (Figure 1A). This evidence concerns the gene PARP10 and cancer.